Related references
Note: Only part of the references are listed.Comparative 12-month retention rate, effectiveness and tolerability of perampanel when used as a first add-on or a late add-on treatment in patients with focal epilepsies: The COM-PER study
Nuno Canas et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)
Perampanel effectiveness and safety as early add-on treatment for focal-onset seizures: PEREAGAL study
X. Rodriguez-Osorio et al.
EPILEPSY RESEARCH (2021)
First add-on perampanel for focal-onset seizures: An open-label, prospective study
Ji Hyun Kim et al.
ACTA NEUROLOGICA SCANDINAVICA (2020)
Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON)
Javier Abril Jaramillo et al.
EPILEPSY & BEHAVIOR (2020)
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a real world context: focus on temporal lobe epilepsy
Angelo Pascarella et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs
Estevo Santamarina et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2020)
Efficacy and safety of perampanel in generalized and focal to bilateral tonic-clonic seizures: A comparative study of Asian and non-Asian populations
Takuji Nishida et al.
EPILEPSIA (2019)
Efficacy and impact on cognitive functions and quality of life of perampanel as first add-on therapy in patients with epilepsy: A retrospective study
Raffaele Rea et al.
EPILEPSY & BEHAVIOR (2019)
Effectiveness of perampanel as a first add-on antiepileptic drug for the treatment of partial epilepsy
Satoru Takahashi et al.
EPILEPSY & BEHAVIOR (2019)
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307
Gregory L. Krauss et al.
EPILEPSIA (2018)
Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study
Vicente Villanueva et al.
EPILEPSIA (2018)
Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study
T. Nishida et al.
ACTA NEUROLOGICA SCANDINAVICA (2018)
Adjunctive perampanel for refractory partial-onset seizures Randomized phase III study 304
Jacqueline A. French et al.
NEUROLOGY (2012)
Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs
Deana M. Gazzola et al.
EPILEPSIA (2007)
Share Paper
